Increased serum thromboxane A2 and prostacyclin but lower complement C3 and C4 levels in COVID-19: associations with chest CT-scan anomalies and lowered peripheral oxygen saturation

Hussein Kadhem Al-Hakeim, Shaymaa Ali Al-Hamami, Michael Maes
doi: https://doi.org/10.1101/2021.04.10.21255240

Article usage

Article usage: April 2021 to December 2024

AbstractFullPdf
Apr 20216611368
May 20211335122
Jun 2021882921
Jul 2021612118
Aug 20211232119
Sep 2021552923
Oct 2021542637
Nov 2021611225
Dec 202155623
Jan 2022591014
Feb 202225146
Mar 202220102
Apr 202232128
May 2022291411
Jun 2022201173
Jul 202224877
Aug 202222106
Sep 20223088
Oct 20222437
Nov 20221634
Dec 2022181219
Jan 20232448
Feb 20232088
Mar 20231628
Apr 202324512
May 20231235
Jun 2023656
Jul 2023855
Aug 202317115
Sep 2023872
Oct 20231222
Nov 2023241714
Dec 20231344
Jan 2024902
Feb 20241258
Mar 20241466
Apr 20241261
May 20241559
Jun 20241154
Jul 20241246
Aug 20241436
Sep 20249611
Oct 2024626
Nov 202412012
Dec 2024466
Back to top
Posted April 13, 2021.
Download PDF
Data/Code
Email
Increased serum thromboxane A2 and prostacyclin but lower complement C3 and C4 levels in COVID-19: associations with chest CT-scan anomalies and lowered peripheral oxygen saturation
Hussein Kadhem Al-Hakeim, Shaymaa Ali Al-Hamami, Michael Maes
medRxiv 2021.04.10.21255240; doi: https://doi.org/10.1101/2021.04.10.21255240
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area